Breast MRI for Cancer Detection and Characterization. A Review of Evidence-Based Clinical Applications

Academic Radiology

Volumn 15, Issue 4, 2008, Pages 408-416

  DeMartini, Wendy ^a   Lehman, Constance ^a   Partridge, Savannah ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Breast cancer; magnetic resonance imaging

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; DIAGNOSTIC ACCURACY; EVIDENCE BASED MEDICINE; HUMAN; LABORATORY DIAGNOSIS; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ULTRASOUND;

BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 40649122384     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2007.11.006     Document Type: Article

References (72)

1. ACR. ACR BI-RADS-magnetic resonance imaging. ACR Breast Imaging Reporting and Data System, Breast Imaging Atlas. Reston, VA: ACR, 2003.
2. Mansfield P., Morris P.G., Ordidge R., et al. Carcinoma of the breast imaged by nuclear magnetic resonance (NMR). Br J Radiol 52 (1979) 242-243
3. Tilanus-Linthorst M.M., Obdeijn I.M., Bartels K.C., et al. First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 63 (2000) 53-60
4. Podo F., Sardanelli F., Canese R., et al. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res 21 (2002) 115-124
5. Morris E.A., Liberman L., Ballon D.J., et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 181 (2003) 619-626
6. Kriege M., Brekelmans C.T., Boetes C., et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351 (2004) 427-437
7. Warner E., Plewes D.B., Hill K.A., et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292 (2004) 1317-1325
8. Kuhl C.K., Schrading S., Leutner C.C., et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23 (2005) 8469-8476
9. Lehman C.D., Blume J.D., Weatherall P., et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 103 (2005) 1898-1905
10. Leach M.O., Boggis C.R., Dixon A.K., et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365 (2005) 1769-1778
11. Lehman C.D., Isaacs C., Schnall M.D., et al. Cancer yield of mammography, MRI, and ultrasound in high risk women: Prospective Multi-institution Breast Cancer Screening Study. Radiology 244 (2007) 381-388
12. Sardanelli F., Podo F., D'Agnolo G., et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 242 (2007) 698-715
13. Saslow D., Boetes C., Burke W., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57 (2007) 75-89
14. Harms S.E., Flamig D.P., Hesley K.L., et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 187 (1993) 493-501
15. Orel S.G., Schnall M.D., Powell C.M., et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 196 (1995) 115-122
16. Mumtaz H., Hall-Craggs M.A., Davidson T., et al. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 169 (1997) 417-424
17. Fischer U., Kopka L., and Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213 (1999) 881-888
18. Bedrosian I., Mick R., Orel S.G., et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 98 (2003) 468-473
19. Liberman L., Morris E.A., Dershaw D.D., et al. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol 180 (2003) 901-910
20. Schelfout K., Van Goethem M., Kersschot E., et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol 30 (2004) 501-507
21. Schnall M.D., Blume J., Bluemke D.A., et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol 92 (2005) 32-38
22. Tan J.E., Orel S.G., Schnall M.D., et al. Role of magnetic resonance imaging and magnetic resonance imaging-guided surgery in the evaluation of patients with early-stage breast cancer for breast conservation treatment. Am J Clin Oncol 22 (1999) 414-418
23. Tillman G.F., Orel S.G., Schnall M.D., et al. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol 20 (2002) 3413-3423
24. Berg W.A., Gutierrez L., NessAiver M.S., et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233 (2004) 830-849
25. Fischer U., Zachariae O., Baum F., et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 14 (2004) 1725-1731
26. Rieber A., Merkle E., Bohm W., et al. MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr 21 (1997) 773-779
27. Slanetz P.J., Edmister W.B., Yeh E.D., et al. Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J 8 (2002) 145-148
28. Liberman L., Morris E.A., Kim C.M., et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 180 (2003) 333-341
29. Lee S.G., Orel S.G., Woo I.J., et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 226 (2003) 773-778
30. Viehweg P., Rotter K., Laniado M., et al. MR imaging of the contralateral breast in patients after breast-conserving therapy. Eur Radiol 14 (2004) 402-408
31. Pediconi F., Catalano C., Roselli A., et al. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. Radiology 243 (2007) 670-680
32. Lehman C.D., Blume J.D., Thickman D., et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol 92 (2005) 9-16
33. Lehman C.D., Gatsonis C., Kuhl C.K., et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356 (2007) 1295-1303
34. Fisher B., Bryant J., Wolmark N., et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16 (1998) 2672-2685
35. Wolmark N., Wang J., Mamounas E., et al. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr (2001) 96-102
36. Martincich L., Montemurro F., De Rosa G., et al. Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 83 (2004) 67-76
37. Pickles M.D., Lowry M., Manton D.J., et al. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 91 (2005) 1-10
38. Padhani A.R., Hayes C., Assersohn L., et al. Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results. Radiology 239 (2006) 361-374
39. Cheung Y.C., Chen S.C., Su M.Y., et al. Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI. Breast Cancer Res Treat 78 (2003) 51-58
40. Manton D.J., Chaturvedi A., Hubbard A., et al. Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. Br J Cancer 94 (2006) 427-435
41. Wasser K., Klein S.K., Fink C., et al. Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution. Eur Radiol 13 (2003) 80-87
42. Murata Y., Ogawa Y., Yoshida S., et al. Utility of initial MRI for predicting extent of residual disease after neoadjuvant chemotherapy: analysis of 70 breast cancer patients. Oncol Rep 12 (2004) 1257-1262
43. Esserman L., Kaplan E., Partridge S., et al. MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol 8 (2001) 549-559
44. Martincich L., Montemurro F., Cirillo S., et al. Role of magnetic resonance imaging in the prediction of tumor response in patients with locally advanced breast cancer receiving neoadjuvant chemo-therapy. Radiol Med (Torino) 106 (2003) 51-58
45. Rosen E.L., Blackwell K.L., Baker J.A., et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 181 (2003) 1275-1282
46. Weatherall P.T., Evans G.F., Metzger G.J., et al. MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation. J Magn Reson Imaging 13 (2001) 868-875
47. Balu-Maestro C., Chapellier C., Bleuse A., et al. Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res Treat 72 (2002) 145-152
48. Partridge S.C., Gibbs J.E., Lu Y., et al. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 179 (2002) 1193-1199
49. Abraham D.C., Jones R.C., Jones S.E., et al. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 78 (1996) 91-100
50. Esserman L., Hylton N., Yassa L., et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 17 (1999) 110-119
51. Chen X., Moore M.O., Lehman C.D., et al. Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy. Acad Radiol 11 (2004) 1115-1124
52. Rieber A., Zeitler H., Rosenthal H., et al. MRI of breast cancer: influence of chemotherapy on sensitivity. Br J Radiol 70 (1997) 452-458
53. DeMartini W.B., Lehman C.D., Peacock S., et al. Computer-aided detection applied to breast MRI: assessment of CAD-generated enhancement and tumor sizes in breast cancers before and after neoadjuvant chemotherapy. Acad Radiol 12 (2005) 806-814
54. Tench D.W., and Page D.L. The unknown primary presenting with axillary lymphadenopathy. In: Bland K.I., and Copeland I.M. (Eds). The breast: comprehensive management of benign and malignant diseases (1998), W.B. Saunders, Philadelphia 1447-1452
55. Stomper P.C., Waddell B.E., Edge S.B., et al. Breast MRI in the evaluation of patients with occult primary breast carcinoma. Breast J 5 (1999) 230-234
56. Henry-Tillman R.S., Harms S.E., Westbrook K.C., et al. Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy. Am J Surg 178 (1999) 496-500
57. Orel S.G., Weinstein S.P., Schnall M.D., et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 212 (1999) 543-549
58. Obdeijn I.M., Brouwers-Kuyper E.M., Tilanus-Linthorst M.M., et al. MR imaging-guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast. AJR Am J Roentgenol 174 (2000) 1079-1084
59. Olson Jr. J.A., Morris E.A., Van Zee K.J., et al. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol 7 (2000) 411-415
60. Buchanan C.L., Morris E.A., Dorn P.L., et al. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol 12 (2005) 1045-1053
61. Bluemke D.A., Gatsonis C.A., Chen M.H., et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA 292 (2004) 2735-2742
62. Kuhl C.K., Jost P., Morakkabati N., et al. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience. Radiology 239 (2006) 666-676
63. Kuhl C.K., Kooijman H., Gieseke J., et al. Effect of B1 inhomogeneity on breast MR imaging at 3.0 T. Radiology 244 (2007) 929-930
64. Sinha S., Lucas-Quesada F.A., Sinha U., et al. In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging 15 (2002) 693-704
65. Guo Y., Cai Y.Q., Cai Z.L., et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 16 (2002) 172-178
66. Woodhams R., Matsunaga K., Kan S., et al. ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 4 (2005) 35-42
67. Rubesova E., Grell A.S., De Maertelaer V., et al. Quantitative diffusion imaging in breast cancer: a clinical prospective study. J Magn Reson Imaging 24 (2006) 319-324
68. Chenevert T.L., Stegman L.D., Taylor J.M., et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 92 (2000) 2029-2036
69. Theilmann R.J., Borders R., Trouard T.P., et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 6 (2004) 831-837
70. Pickles M.D., Gibbs P., Lowry M., et al. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24 (2006) 843-847
71. 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T. Radiology 236 (2005) 465-475
72. Meisamy S., Bolan P.J., Baker E.H., et al. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy-a pilot study at 4 T. Radiology 233 (2004) 424-431